Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of hepatic cell growth regulatory factor tyrosine kinase substrate in prevention and/or treatment of EV71 infection

A technology for growth regulators and tyrosine kinases, which is used in medical preparations containing active ingredients, peptide/protein ingredients, antiviral agents, etc.

Active Publication Date: 2015-09-09
浙江安维珞诊断技术有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the preventive and therapeutic effects of HGS on the current popular and highly pathogenic enterovirus type 71 (EV71).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of hepatic cell growth regulatory factor tyrosine kinase substrate in prevention and/or treatment of EV71 infection
  • Application of hepatic cell growth regulatory factor tyrosine kinase substrate in prevention and/or treatment of EV71 infection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 Preparation of hepatocyte growth regulator factor tyrosine kinase substrate

[0024] (1) Cloning of the hepatocyte growth regulator tyrosine kinase substrate gene: using the total mRNA extracted from human blood leukocytes as a template, the total cDNA was first amplified by reverse transcription PCR, and then the cDNA was used as a template to use specific The primers amplified the complete HGS gene fragment. Primers are as follows:

[0025] P1 (forward primer): 5'-AA GGATCC ATGGGGCGAGGCAGCGG-3', BamHI,

[0026] P2 (reverse primer): 5'-AA CTCGAG TCAGTCGAATGAAATGA-3', XhoI.

[0027] The HGS gene was cloned under the pTAC promoter of the vector pGEX-6p-1 by restriction digestion and ligation of BamHI and XhoI to obtain the expression vector pGEX-6p-1-HGS of HGS.

[0028] (2) Acquisition of Escherichia coli expressing hepatocyte growth regulator factor tyrosine kinase substrate: the above expression vector pGEX-6p-1-HGS was transformed into Escherichia co...

Embodiment 2

[0031] Example 2 Detection of toxicity of hepatocyte growth regulator factor tyrosine kinase substrate to host cells

[0032] After 24-48 hours of culturing human malignant embryonic rhabdomyosarcoma cells (rhabdomyosarcoma, RD) grow into a single layer (MEM medium + 10% fetal bovine serum culture), discard the culture medium, add trypsin to digest, transfer to 96-well sterile In a cell culture plate, 100 μL per well, placed at 37°C, 5% CO 2 Culture in the cell incubator for 18-24h to make the cells grow into a single layer, discard the supernatant. The HGS cryopreservation solution obtained in Example 1 was diluted step by step with serum-free MEM cell culture medium, and prepared into four concentration gradients of 8, 40, 200, and 1000 μg / mL, and then added different concentrations of HGS protein solution and discarded In the cell culture wells of the supernatant, 100 μL per well, repeat 3 wells for each concentration, and set up cell control wells (without adding drugs, o...

Embodiment 3

[0036] Example 3 Anti-EV71 virus effect of hepatocyte growth regulator factor tyrosine kinase substrate

[0037] After 24-48 hours of culture, human malignant embryonic rhabdomyosarcoma cells (RD cells) grow into a single layer (MEM medium + 10% fetal bovine serum), discard the culture medium, add trypsin to digest, and transfer to 96-well sterile cells In the culture plate, 100 μL per well, placed at 37 ° C, 5% CO 2 Culture in the cell incubator for 18-24h to make the cells grow into a single layer, discard the supernatant. Add HGS protein solutions diluted with serum-free MEM cell culture medium to a final concentration of 0.6, 1.2, 2.5, 5, 10, and 20 μg / mL, and incubate for 24 hours and then infect with EV71 virus. The multiplicity of infection (MOI) The MOI was 5, and the samples were collected after 12 hours to detect the mRNA level and protein level of EV71VP1 by Realtime PCR and Western Blot respectively. Among them, Western Blot uses β-actin as an internal reference,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a hepatic cell growth regulatory factor tyrosine kinase substrate (HGS) in prevention and / or treatment of EV71 infection and belongs to the field of antiviral drugs. HGS protein is added into cells, then EV71 is added, and RNA level and protein level of EV71 VP1 are detected, and results show that mRNA level and protein level of VP1 are obviously reduced compared with the cells added with no HGS and are in a dose-dependent manner, so that HGS has anti-EV71 effect; further influence of HGS on survival rate of the cells infected with EV71 can be detected, results show that the survival rate of the cells added with HGS is obviously higher than that of a virus control group, and the HGS protein has the effect of inhibiting viruses when being added before or after EV71 infection, namely HGS has the effect of preventing and treating EV71 infection. The invention finds new medicinal value of HGS, and HGS can be used for preparing an anti-EV71 medicine and a medicine used for preventing and / or treating EV71 infection.

Description

technical field [0001] The present invention relates to the field of antiviral drugs, and relates to the new application of hepatocyte growth factor-regulated tyrosine kinase substrate (hepatocyte growth factor-regulated tyrosine kinase substrate, HGS), specifically its prevention and / or treatment of enterovirus Type 71 (EV71) infection drug application. Background technique [0002] Human enterovirus 71 (EV71 for short) belongs to the genus Enterovirus of the Picornaviridae family, and is a popular virus that acts on the nervous system of children. The human enterovirus 71 strain was first isolated in 1969 from infected neurological disease cases in California, USA. Rarely, EV71 can cause a disease like polio-like permanent paralysis. [0003] The EV71 virus mainly causes herpes to develop on the hands, feet, and mouth of infants, so the disease is named Hand, Foot, and Mouth Disease (HFMD). From 1970 to the present, EV71 has exploded in the Americas, Europe and the Asia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61P31/14
Inventor 邬开朗吴建国乔智罗震刘芳金晶
Owner 浙江安维珞诊断技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com